Providing flexible operations for new biopharm filling facility

Novo Nordisk has established a new biopharm filling facility in Kalundborg. The facility serves as a multipurpose site working with biopharmaceutical products such as NovoSeven® for haemophilia patients and Glucagen® for treatment of low levels of blood glucose. NNE provided support in all engineering disciplines.

The 10,000 m2 facility was the solution to Novo Nordisk’s space issue. The company needed a back-up to what it already had, so the new location supplements its existing facilities in Gentofte.

What makes this a complex facility is the fact that it is so dense. It has more than 150 rooms - many of them very small - and when everyone wants to work on their part at the same time, scheduling is very important,” says NNE project manager Torben Kløvborg-Laustsen.

The cleanrooms and the HVAC installations especially were highly complex and time-consuming aspects that required excellent space management.

For this huge facility, NNE provided conceptual design, basic design, EPCMV (engineering, procurement, construction management and validation) and support in all engineering disciplines.

Overall, Novo Nordisk was satisfied with the performance of the project, the support and the way NNE handled the difficult turns the project took. NNE was able to adapt to the changes in priority that occurred along the way, as well as the unexpected challenge of dealing with water damage, which suddenly happened at the end of the project.

We are very satisfied with the final result of the facility. I’m impressed by the quality, which is well-integrated, and the appearance of the facility is remarkable,” says CVP for Biopharm Aseptic Production in Novo Nordisk, Henrik Friese.

In spite of the turbulent conditions throughout the project, it was completed in three years (2011-2014). The first products will be delivered to the market in 2017. The Biopharm filling facility in Kalundborg is expected to double the capacity for the Biopharm filling division of Novo Nordisk.

We are very satisfied with the final result of the facility. I’m impressed by the quality, which is well-integrated, and the appearance of the facility is remarkable.

Henrik Friese, CVP for Biopharm Aseptic Production, Novo Nordisk

Quick facts

Customer

Novo Nordisk

Country

Denmark

Project duration

Feb. 2011 – Aug. 2014

Services provided

Conceptual design, basic design, EPCMV contract (engineering, procurement, construction management and validation) and support in all engineering disciplines